Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer

The EXTREME protocol is the standard of care for recurrent or metastatic head and neck squamous-cell carcinoma (R/M HNSCC) in first line. Beyond the first-line except immunotherapy, poor efficacy was reported by second-line chemotherapy. Re-challenge strategies based on a repetition of the first lin...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncotarget 2018-12, Vol.9 (101), p.37581-37588
Hauptverfasser:	Borel, Christian, Regnier-Gavier, Olivier, Carinato, Hélène, Guihard, Sébastien, Antoni, Delphine, Demarchi, Martin, Sirlin, Florian, Exinger, Delphine, Petit-Jean, Emilie, Thiery, Alicia, Bronner, Guy, Schultz, Philippe, Flesch, Henri, Frasie, Véronique, Prébay, Danielle, Petit, Thierry, Jung, Alain C, Burgy, Mickael, Coliat, Pierre
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Life Sciences Pharmaceutical sciences Pharmacology Research Paper
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!